Current Treatment Recommendations in Antiarrhythmic Therapy
- 1 January 1998
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 55 (3) , 331-346
- https://doi.org/10.2165/00003495-199855030-00002
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: A multicenter, randomized, double-blind, placebo-controlled studyAmerican Heart Journal, 1995
- The Treatment of Atrial FibrillationDrugs, 1994
- Significance of Classifying Antiarrhythmic Actions Since the Cardiac Arrhythmia Suppression TrialThe Journal of Clinical Pharmacology, 1991
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- AmiodaroneNew England Journal of Medicine, 1987
- Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator.Circulation, 1985
- A Classification of Antiarrhythmic Actions Reassessed After a Decade of New DrugsThe Journal of Clinical Pharmacology, 1984
- Ventricular premature complexes and sudden death after myocardial infarction.Circulation, 1981
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981
- Termination of Malignant Ventricular Arrhythmias with an Implanted Automatic Defibrillator in Human BeingsNew England Journal of Medicine, 1980